Lower sAPPα levels have been found in cerebro-spinal fluid of Alzheimer’s disease patients carrying the Swedish mutations in APP [48] and in post mortem brain [49], but pre-mortem studies in cerebro-spinal fluid or blood in patients with sporadic Alzheimer’s disease have not provided consistent results [50]. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.